ID: ALA4797405

Max Phase: Preclinical

Molecular Formula: C38H41N9O11S

Molecular Weight: 831.87

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCCOCCOCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1

Standard InChI:  InChI=1S/C38H41N9O11S/c1-39-34(51)31-35(43-36(59-31)23-9-10-40-28(19-23)41-32(49)22-5-6-22)57-18-17-56-16-15-55-14-13-54-12-11-46-20-24(44-45-46)21-58-27-4-2-3-25-30(27)38(53)47(37(25)52)26-7-8-29(48)42-33(26)50/h2-4,9-10,19-20,22,26H,5-8,11-18,21H2,1H3,(H,39,51)(H,40,41,49)(H,42,48,50)

Standard InChI Key:  FEICDSOLEYDNQO-UHFFFAOYSA-N

Associated Targets(Human)

GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gsk3b Cereblon/Glycogen synthase kinase-3 beta (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 831.87Molecular Weight (Monoisotopic): 831.2646AlogP: 1.61#Rotatable Bonds: 21
Polar Surface Area: 244.39Molecular Species: NEUTRALHBA: 17HBD: 3
#RO5 Violations: 2HBA (Lipinski): 20HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.43CX Basic pKa: 2.20CX LogP: 1.09CX LogD: 1.09
Aromatic Rings: 4Heavy Atoms: 59QED Weighted: 0.08Np Likeness Score: -1.33

References

1. Jiang X,Zhou J,Wang Y,Liu X,Xu K,Xu J,Feng F,Sun H.  (2021)  PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases.,  210  [PMID:33097303] [10.1016/j.ejmech.2020.112949]

Source